CF PharmTech Repurchases 17,500 H-Shares, Treasury Stock Rises to 753,000 Shares

Bulletin Express05-14

CF PharmTech, Inc. disclosed that it bought back 17,500 H-shares on 14 May 2026 via on-market transactions, paying an aggregate HKD 0.37 million at prices ranging between HKD 20.68 and HKD 21.42 per share. The volume-weighted average cost stood at HKD 20.96 per share.

Following the transaction, the company’s issued share capital (excluding treasury shares) declined marginally by 0.0058 % to 301.47 million shares. Treasury share holdings increased from 735,500 to 753,000 shares, while total issued shares remained unchanged at 302.22 million.

The repurchase was executed under the mandate granted on 16 December 2025, which authorises the company to buy back up to 30.22 million shares. Cumulative buybacks under this mandate now total 753,000 shares, representing 0.25 % of the shares in issue on the mandate date.

In accordance with Hong Kong Stock Exchange rules, CF PharmTech is subject to a moratorium on new share issues or sales of treasury shares until 13 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128522291?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128522291","market":"hk","top_or_hot":-1,"title":"CF PharmTech Repurchases 17,500 H-Shares, Treasury Stock Rises to 753,000 Shares","media":"Bulletin Express","content":"<p>CF PharmTech, Inc. disclosed that it bought back 17,500 H-shares on 14 May 2026 via on-market transactions, paying an aggregate HKD 0.37 million at prices ranging between HKD 20.68 and HKD 21.42 per share. The volume-weighted average cost stood at HKD 20.96 per share.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) declined marginally by 0.0058 % to 301.47 million shares. Treasury share holdings increased from 735,500 to 753,000 shares, while total issued shares remained unchanged at 302.22 million.</p>\n<p>The repurchase was executed under the mandate granted on 16 December 2025, which authorises the company to buy back up to 30.22 million shares. Cumulative buybacks under this mandate now total 753,000 shares, representing 0.25 % of the shares in issue on the mandate date.</p>\n<p>In accordance with Hong Kong Stock Exchange rules, CF PharmTech is subject to a moratorium on new share issues or sales of treasury shares until 13 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech Repurchases 17,500 H-Shares, Treasury Stock Rises to 753,000 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech Repurchases 17,500 H-Shares, Treasury Stock Rises to 753,000 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-14 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech, Inc. disclosed that it bought back 17,500 H-shares on 14 May 2026 via on-market transactions, paying an aggregate HKD 0.37 million at prices ranging between HKD 20.68 and HKD 21.42 per share. The volume-weighted average cost stood at HKD 20.96 per share.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) declined marginally by 0.0058 % to 301.47 million shares. Treasury share holdings increased from 735,500 to 753,000 shares, while total issued shares remained unchanged at 302.22 million.</p>\n<p>The repurchase was executed under the mandate granted on 16 December 2025, which authorises the company to buy back up to 30.22 million shares. Cumulative buybacks under this mandate now total 753,000 shares, representing 0.25 % of the shares in issue on the mandate date.</p>\n<p>In accordance with Hong Kong Stock Exchange rules, CF PharmTech is subject to a moratorium on new share issues or sales of treasury shares until 13 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1128522291","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128522291","pubTimestamp":1778756616,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech, Inc. disclosed that it bought back 17,500 H-shares on 14 May 2026 via on-market transactions, paying an aggregate HKD 0.37 million at prices ranging between HKD 20.68 and HKD 21.42 per...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech回购1.75万股H股库存股升至75.3万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech, Inc. disclosed that it bought back 17,500 H-shares on 14 May 2026 via on-market transactions, paying an aggregate HKD 0.37 million at prices ranging between HKD 20.68 and HKD 21.42 per share. The volume-weighted average cost stood at HKD 20.96 per share.\nFollowing the transaction, the company’s issued share capital (excluding treasury shares) declined marginally by 0.0058 % to 301.47 million shares. Treasury share holdings increased from 735,500 to 753,000 shares, while total issued shares remained unchanged at 302.22 million.\nThe repurchase was executed under the mandate granted on 16 December 2025, which authorises the company to buy back up to 30.22 million shares. Cumulative buybacks under this mandate now total 753,000 shares, representing 0.25 % of the shares in issue on the mandate date.\nIn accordance with Hong Kong Stock Exchange rules, CF PharmTech is subject to a moratorium on new share issues or sales of treasury shares until 13 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128522291","isCrawlerRequest":true}